Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study.
about
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@en
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@nl
type
label
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@en
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@nl
prefLabel
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@en
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@nl
P2093
P2860
P1476
Serum pharmacokinetics and cer ...... le sclerosis: A Phase 1 study.
@en
P2093
Alois B Lang
Arno Kromminga
Corinne Bernard
François Curtin
Hervé Porchet
Virginie Vidal
P2860
P304
P356
10.1080/19420862.2016.1168956
P577
2016-03-30T00:00:00Z